Germany · Delayed Price · Currency is EUR Evotec SE Statistics
Total Valuation
Evotec SE has a market cap or net worth of EUR 908.30 million. The enterprise value is 851.00 million.
| Market Cap | 908.30M |
| Enterprise Value | 851.00M |
Important Dates
The next confirmed earnings date is Thursday, August 13, 2026.
| Earnings Date | Aug 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Evotec SE has 177.75 million shares outstanding. The number of shares has increased by 0.13% in one year.
| Current Share Class | 177.75M |
| Shares Outstanding | 177.75M |
| Shares Change (YoY) | +0.13% |
| Shares Change (QoQ) | +0.02% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 35.63% |
| Float | 133.55M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.22 |
| PB Ratio | 1.30 |
| P/TBV Ratio | 2.30 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 48.54 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -4.39 |
| EV / Sales | 1.14 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -21.39 |
Financial Position
The company has a current ratio of 1.68, with a Debt / Equity ratio of 0.55.
| Current Ratio | 1.68 |
| Quick Ratio | 1.45 |
| Debt / Equity | 0.55 |
| Debt / EBITDA | 129.50 |
| Debt / FCF | -9.74 |
| Interest Coverage | -512.13 |
Financial Efficiency
Return on equity (ROE) is -24.06% and return on invested capital (ROIC) is -12.63%.
| Return on Equity (ROE) | -24.06% |
| Return on Assets (ROA) | -3.14% |
| Return on Invested Capital (ROIC) | -12.63% |
| Return on Capital Employed (ROCE) | -7.41% |
| Weighted Average Cost of Capital (WACC) | 8.01% |
| Revenue Per Employee | 164,613 |
| Profits Per Employee | -42,836 |
| Employee Count | 4,526 |
| Asset Turnover | 0.42 |
| Inventory Turnover | 20.02 |
Taxes
In the past 12 months, Evotec SE has paid 14.78 million in taxes.
| Income Tax | 14.78M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -24.93% in the last 52 weeks. The beta is 1.30, so Evotec SE's price volatility has been higher than the market average.
| Beta (5Y) | 1.30 |
| 52-Week Price Change | -24.93% |
| 50-Day Moving Average | 4.92 |
| 200-Day Moving Average | 5.69 |
| Relative Strength Index (RSI) | 56.31 |
| Average Volume (20 Days) | 860,981 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Evotec SE had revenue of EUR 745.04 million and -193.88 million in losses. Loss per share was -1.09.
| Revenue | 745.04M |
| Gross Profit | 79.42M |
| Operating Income | -90.13M |
| Pretax Income | -179.10M |
| Net Income | -193.88M |
| EBITDA | -16.69M |
| EBIT | -90.13M |
| Loss Per Share | -1.09 |
Balance Sheet
The company has 444.76 million in cash and 387.46 million in debt, with a net cash position of 57.30 million or 0.32 per share.
| Cash & Cash Equivalents | 444.76M |
| Total Debt | 387.46M |
| Net Cash | 57.30M |
| Net Cash Per Share | 0.32 |
| Equity (Book Value) | 699.62M |
| Book Value Per Share | 3.94 |
| Working Capital | 287.90M |
Cash Flow
In the last 12 months, operating cash flow was 18.71 million and capital expenditures -58.51 million, giving a free cash flow of -39.79 million.
| Operating Cash Flow | 18.71M |
| Capital Expenditures | -58.51M |
| Depreciation & Amortization | 73.45M |
| Net Borrowing | -84.73M |
| Free Cash Flow | -39.79M |
| FCF Per Share | -0.22 |
Margins
Gross margin is 10.66%, with operating and profit margins of -12.10% and -26.02%.
| Gross Margin | 10.66% |
| Operating Margin | -12.10% |
| Pretax Margin | -24.04% |
| Profit Margin | -26.02% |
| EBITDA Margin | -2.24% |
| EBIT Margin | -12.10% |
| FCF Margin | n/a |
Dividends & Yields
Evotec SE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.13% |
| Shareholder Yield | -0.13% |
| Earnings Yield | -21.34% |
| FCF Yield | -4.38% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Analyst Forecast
The average price target for Evotec SE is 6.44, which is 21.97% higher than the current price. The consensus rating is "Buy".
| Price Target | 6.44 |
| Price Target Difference | 21.97% |
| Analyst Consensus | Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on August 18, 2000. It was a forward split with a ratio of 2.
| Last Split Date | Aug 18, 2000 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
Evotec SE has an Altman Z-Score of 0.42 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.42 |
| Piotroski F-Score | 4 |